Endoscopic ultrasound guided portal pressure gradient: safety aspects, clinical relevance and technical issues to improve the procedure

Autor: Rafael Romero-Castro, Victoria A. Jiménez- García, Isabel Carmona-Soria, María Tous-Romero, Paula Fernandez-Alvarez, Álvaro Gutiérrez-Domingo, Patricia Cordero-Ruiz, Francisco Bellido-Muñoz, José Cáceres Galán, Manuel Rodriguez-Tellez, Ángel Caunedo Álvarez

Publikováno v: Annals of Hepatology, Vol 29, Iss , Pp 101454- (2024)

Introduction and Objectives: Endoscopic ultrasound guided portal pressure gradient measurement (EUS-PPGm) would provide useful clinical information in patients with liver diseases. However, there is yet scarcely data on the clinical relevance of this

Externí odkaz: https://doaj.org/article/8ff3ab57c58f4f47ae527fb14906e8b2

Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments

Autor: Monica Perona, Agnese Miranda, Inés Ariño, Judith Gomez-Camarero, Marco Romano, Luis Ferrer-Barceló, Jesús Barrio, Judith Millastre, Blas J. Gomez, Fernando Bermejo, Ángeles Pérez-Aisa, Juan Ortuño, Ines Modolell, Pedro Almela, Antonietta Gerarda Gravina, Nuria Fernández, Marco Martorano, Adrian G. McNicholl, Alfredo J. Lucendo, Jose Luis Domínguez, Teresa Angueira, Elisa Martin-Noguerol, Enrique Medina, Javier Molina-Infante, Javier P. Gisbert, Juan Enrique Domínguez-Muñoz, Manuel Rodríguez-Tellez, Miguel Fernández-Bermejo, Alessandro Federico, Alicia C Marin

Publikováno v: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Background: Aim was to evaluate the efficacy and tolerability of a moxifloxacin-containing second-line triple regimen in patients whose previous Helicobacter pylori eradication treatment failed. Methods: Prospective multicentre study including patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db2ada9a05276a8c8f307c28808c193a
https://pubmed.ncbi.nlm.nih.gov/25454706

Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva

Autor: Cristóbal de-la-Coba, Federico Argüelles-Arias, Carlos Martín-de-Argila, Javier Júdez, Antonio Linares, Aida Ortega-Alonso, Enrique Rodríguez, Manuel Rodríguez-Téllez, Isabel Vera, Lara Aguilera, Ángel Álvarez, Raúl J. Andrade, Fidencio Bao, Manuel Castro, Froilán Giganto

Publikováno v: Revista Espanola de Enfermedades Digestivas, Vol 108, Iss 4, Pp 207-224 (2016)

Introduction: In the last few years a significant number of papers have related the use of proton-pump inhibitors (PPIs) to potential serious adverse effects that have resulted in social unrest. Objective: The goal of this paper was to provide a lite

Externí odkaz: https://doaj.org/article/b2f74844ec3446fe9d69cacf32fded51

Epidemiology of Barrett's esophagus and esophageal adenocarcinoma in Spain: a unicentric study

Autor: Quetzalihuitl Arroyo-Martínez, Manuel Rodríguez-Téllez, Antonio García-Escudero, Javier Brugal-Medina, Ricardo González-Cámpora, Ángel Caunedo-Álvarez

Publikováno v: Revista Espanola de Enfermedades Digestivas, Vol 108, Iss 10, Pp 609-617

Background: Barrett's esophagus (BE) is an acquired disease defined by the presence of intestinal metaplasia with goblet cells in the distal esophagus. The prevalence of BE has increased dramatically over the last years. Aims: The primary aims of the

Externí odkaz: https://doaj.org/article/84f5b27e0c3d43eca019773b0bfa4a44